KPV for Gut Health: What the Evidence Shows
What human and animal studies show about KPV for gut health, how strong that evidence is, and what is still unproven.
- Strongest evidence
- Animal
- Human studies
- 4
- PubMed records, our ledger
- Animal studies
- 6
- PubMed records, our ledger
- Studies we summarised
- 2
- with an outcome for gut health
Evidence for gut health
Each row is an outcome related to gut health from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| DSS colitis recovery | KPV-treated mice recovered earlier and regained more body weight in DSS colitis. | Animal · mouse (not a human result) | Inflammatory bowel diseases 2008, PMID 18092346 |
| Survival in MC1R-nonfunctional mice | KPV treatment rescued all treated MC1R-nonfunctional mice from death during DSS colitis. | Animal · mouse (not a human result) | Inflammatory bowel diseases 2008, PMID 18092346 |
| Colitis incidence (oral KPV) | Oral KPV in drinking water reduced the incidence of DSS- and TNBS-induced colitis in mice and lowered inflammatory cytokine expression. | Animal · mouse (plus human intestinal epithelial and T cell lines) (not a human result) | Gastroenterology 2008, PMID 18061177 |
PubMed records for KPV and gut health: 4 human, 6 animal (search counts, not studies we reviewed). Grades follow our .
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
Gut conditions people mention alongside KPV
MedlinePlus describes ulcerative colitis as a disease causing inflammation and sores in the lining of the rectum and colon, within the inflammatory bowel disease group.[3]
MedlinePlus says irritable bowel syndrome, although it can cause a great deal of discomfort, does not harm the intestines.[4]
What KPV did in mouse colitis
In the mouse DSS-colitis model, KPV led to earlier recovery and a stronger regain of body weight.[1]
In MC1Re/e mice, KPV treatment rescued all animals in the treatment group from death during DSS colitis.[1]
Oral KPV reduced the incidence of DSS- and TNBS-induced colitis in mice, with a decrease in pro-inflammatory cytokine expression.[2]
What has not been tested
The gut PubMed query for KPV (run 2026-10-02) found 13 human-tagged records (4 human-only), 6 animal records and 0 randomized trials among 23 in all.
Calculated from human 13; human only 4; animal 6; rct 0; all 23. Formula: Counts copied from the kpv ledger row of the gut-health goal in goals.json; no arithmetic.
None of the 9 KPV studies in the evidence file enrolled people as participants: they are mouse, rabbit, cell-line and ex vivo skin or assay studies.
Calculated from kpv studies in evidence file 9; human participant studies 0. Formula: Study designs counted from web/src/data/evidence/kpv.json (animal, in-vitro); no arithmetic.
The PepT1 paper's authors say KPV is transported into cells by PepT1 and might be a new therapeutic agent for IBD.[2]
Other peptides people research for gut health
All peptides for gut health, comparedCommon questions
Does KPV help with gut health?
The strongest study we summarise for gut health is animal evidence, across 2 studies with an outcome for gut health. That is not proof it works in people.
Is KPV approved for gut health?
No. KPV is not FDA approved for any use, including gut health.
What is the best peptide for gut health?
There is no single answer. Our gut health overview compares each candidate by evidence grade and legal status rather than by popularity.
Does KPV help ulcerative colitis?
Only in mice so far: colitis models showed earlier recovery and less inflammation, and no human trial is in our files.[1]
Is KPV good for IBS?
The cached KPV work uses colitis models of inflammatory bowel disease, not irritable bowel syndrome, which MedlinePlus says does not harm the intestines.[4]
More on KPV
Sources
- 1Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.Inflammatory bowel diseases · 2008PMID 18092346Accessed 2 Oct 2026
- 2PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.Gastroenterology · 2008PMID 18061177Accessed 2 Oct 2026
- 3Official web pageOfficial web page · web page
- 4medlineplus.gov pagemedlineplus.gov · web pagemedlineplus.gov
Found an error? Report a correction.